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I. INTRODUCTION 
A. Statistical Analysis of Bioassays 
A generally accepted definition of the term bioassay 
(biological assay) as it is used in statistics is that given 
by Finney (15, p. 1). He states that, "Biological assays are 
methods for the estimation of the nature, constitution, or 
potency of a material (or of a process) by means of the reac­
tion that follows its application to living matter . . . 
Quantitative assays, with which we are concerned, are similar 
to methods of physical measurement or of quantitative chemical 
analysis in that their function is to provide numerical assess­
ment of some property of the material to be assayed. An essen­
tial part in this assessment is played by measurement of 
growth or other changes in animals, plants, animal tissue, _ 
micro-organisms, or some other form of living matter. An assay 
is thus a form of biological experiment, but the interest lies 
in comparing the magnitudes of effects of different treat­
ments. The experimental technique may be the same as is used 
in a purely comparative experiment but the difference in 
purpose will affect the optimal experimental design and the 
statistical analysis." For example, an investigation which 
simply aims at determining whether or not two toxins are 
different is not necessarily a bioassay by the above defini­
tion. It becomes one if the experimenter is additionally 
2 
interested in estimating the relative potency of the toxins. 
Bioassays may be classified as being either direct or 
indirect. The principle of a direct assay is that the dose of 
stimulus just sufficient to produce a specified response is 
measured directly. This type of assay is not common because 
technical problems often prevent the experimenter from ensur­
ing that the subjects receive the exact dose required. 
In the more common indirect assays, different doses are 
administered, each to several subjects and the resulting 
responses are observed. If an individual subject's response 
is an "all or none" reaction (such as survival or death) it 
is called a quantal response. Quantal response assays are 
distinguished from quantitative response assays in which the 
magnitude of some property of the subject (such as weight) is 
recorded. This thesis will only be concerned with quantal and 
quantitative response indirect assays. 
Bioassays have found application in a great many scien­
tific fields. Their use can be noted with increasing frequency 
in the literature of immunology, pharmacology, endocrinology, 
entomology, and many other areas of biological and medical 
research. The technique of comparing the effect of an experi­
mental preparation with that of a standard preparation has 
proven to be of great value in helping to "remove" much of the 
variation between experimental units from the comparison of 
two preparations. In bioassays, a specially calculated 
comparison, usually called the relative potency, is expressed 
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as a ratio of equally effective doses. It is sometimes known 
as relative activity or by some other term depending upon the 
field of application. 
The statistical analysis of a bioassay involves the 
f ollowing: 
1. specification of the mathematical model and its 
related assumptions 
2. testing, in some sense, the validity of the model 
and assumptions 
3. providing an estimate of relative potency along with 
appropriate confidence limits. 
The success of a bioassay in providing a numerical assess­
ment of a drug or other material depends to a great extent 
upon the relevance of the model employed to the real situation. 
Frequently a convenient linear model is used as an approxima­
tion to the dose-response relationship. Transformations, 
sometimes called metameters, of both the dose and response 
variables are often used to achieve.this end. 
A considerable amount of research on the development of 
statistical methods of analysis pertinent to bioassays has 
been and is being done. An excellent exposition of the basic 
concepts used in bioassays was published by Jerne and Wood 
(21) in 1949. In this paper they enumerate and examine in 
detail a number of the implicit and explicit assumptions 
involved in using a bioassay model. A standard text in this 
field, which consolidated most of the work through 1952, is 
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that by Finney, "Statistical Method in Biological Assay" (15). 
In this comprehensive book the prominent mathematical models 
and methods in use are discussed and criticized. Cox (11) 
lists over one hundred and fifty references dealing with 
statistical methods in bioassay, most of which have been 
published since 1950. A large number of even more recent 
developments are available in the somewhat scattered litera­
ture and are not cited here. References to works which are 
pertinent to this study are made later where appropriate. 
B. The Tolerance Distribution in Quantal 
Response Bioassays 
The concept of a tolerance distribution has been found 
useful in establishing mathematical models for use in quantal 
response assays. In theory there is an exact dose which is 
just sufficient to cause the response in an individual subject. 
This dose, called the tolerance, varies between subjects even 
within a homogeneous population of subjects. If these toler­
ances could be directly measured, as in a direct assay, they 
would have a frequency distribution. The fact that such 
direct measurements would usually be quite difficult to 
obtain has already been pointed out. Ordinarily several 
different doses are administered, each to a group of subjects 
which are randomly selected from a population. The percentage 
which has responded at each dose is then observed. This 
provides an estimate of the percentage of the parent popula­
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tion which have tolerances less than or equal to that particu­
lar dose. The series of percentages thus obtained approximates 
the cumulative distribution function of the frequency distribu­
tion of tolerances. 
Reference is often made to an LD-50 (lethal dose-50), 
ED-50 (effective dose-50) or a fifty per cent end point in 
quantal response studies. These all refer to the median, 
equivalent to the mean in symmetrical distributions, of the 
hypothetical tolerance distribution. Several different methods 
have been developed for the estimation of this quantity. Some 
specify a parametric model for the cumulative tolerance dis­
tribution such as the cumulative normal or the logistic dis­
tribution. In such cases, if necessary to facilitate estima­
tion, a transformation, such as a probit or logit, is made to 
give a response metameter having a linear relationship with 
a dose metameter (e.g. log dose). 
In the literature, a number of estimators of the LD-50 
have been proposed which do not specify the exact form of the 
tolerance distribution but can be applied to broad classes of 
distributions, such as all symmetric distributions. Whether 
a specific distributional form is used as a model or one of 
these "distribution-free" estimators depends upon several 
factors. Probably the major determining factors in this 
regard are availably knowledge of the distributional form and 
the computational convenience of the methods. Finney (14) has 
reviewed the advantages and disadvantages of most of the 
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various methods. 
C. Some Limitations of Presently Available 
Bioassay Models and Techniques 
1. Monotonicity 
The general situation in a bioassay may be described as 
follows. Let y^ denote the response of a subject, randomly 
selected from a population, receiving a known dose of a 
preparation. Let also E(y^[z^) = Y.. The dose-response rela­
tionship may be expressed as Y^ = F(z^), or Y = F(z), where 
F(z) represents a function of z. The assumption that F(z) is 
a strictly monotonie function of z in the usual dose range is 
a basic requirement of all standard bioassay models. That is, 
for every z. , z., if z. < z. then F(z-) <'F(z . ). It is neces-
1 J 1 J 1 J 
sary that this assumption be true in order to insure that 
comparisons of the effects of different doses (or treatments), 
even at a specific level of Y, be unique and meaningful. The 
occurrence of non-monotonic dose-response functions in studies 
of the effects of Cerium Edetate on mice and guinea pigs has 
been noted by Dr. Joseph Graca of Ames, Iowa, in 1963 (private 
communication). 
2. Similarity 
Another assumption necessary for the estimation of rela­
tive potency by the usual bioassay techniques is known as the 
condition of similarity. For this condition to be true, the 
test preparation (T) must behave as though it were a dilution 
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(or a concentration) of the standard preparation (S) in a 
diluent that is completely 'inert with respect to the response 
used. In this case, it follows that the relative potency, 
p = (the ratio of equally effective doses) is constant for 
ZT 
all Y. The algebraic statement of this condition as it affects 
the dose-response curves is: 
F t ( z t )  =  F g ( z g )  =  F g  ( p z T )  ( 1 )  
for all Zg, Zj. 
If, in this situation, the response curve for the test 
preparation T is Y = a + fijZj) where Y is some response meta­
meter, then by (1), the curve for the standard preparation S 
is Y = a + {BgZg = a + j3g(p z-p ) . This is the standard slope 
ratio assay model where p is estimated by the ratio of the 
slopes of the two fitted regression lines. The intercept, a, 
is common to both lines since it is the expected response to 
a zero dose in each case. 
If a logarithmic transformation of the dose is made, where 
x - log10 dose (z), then z = 10x and, under the condition of 
similarity, it can be seen that 
F^(10*T) = Fg(plO*^) = T + log ^  
as noted by Cox (11). This shows that whatever the form of 
the response curve for T, the curve for S is the same except 
for a horizontal displacement by an amount log p. When, more 
specifically, a linear model is appropriate, parallel regres­
sion lines are usually fitted to the two sets of observations 
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and an estimate of log p is taken as the horizontal distance 
between these two lines. A bioassay in which such a model is 
employed is called a parallel line assay. 
The requirement of similarity for a "valid" assay has 
been stressed by Finney, as quoted by Jerne and Wood (21, 
p. 277), "If the data cannot be adequately described by the 
same form of F for both preparations, the basic assumption 
that only the same effective constituents were concerned in 
both must be false. The assay is therefore invalid." Jerne 
and Wood (21, p. 277) comment, ". . . and it might be added 
that the whole idea of assaying that particular test prepara­
tion against that particular standard preparation becomes 
absurd." Although it should be obvious that validity in this 
sense means validity of the bioassay model to provide a single 
value for relative potency, some confusion on this point is 
apparent. Biologists sometimes find themselves at a loss in 
attempting to interpret bioassay data where the condition of 
similarity clearly does not apply. For example, Gibbs et al. 
(16, p. 408), having encountered such a situation, go so far 
as to state that, ". . .no quantitative comparisons can be 
m a d e  . . . "  
Of course, as most experimenters realize, nature is under 
no obligation to provide data that fit our mathematical models. 
Frequently these are only models of computational and interpre­
tive convenience. There may be no theoretical justification 
for believing that two chemically different substances behave 
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as though one were a diluent of the other. Yet nearly all of 
the statistical literature available on bioassays accept this 
notion as a first requisite. The only exception known to the 
author is the paper by Thompson (29). Some biologists have 
recognized this limitation of bioassay models, and noting such 
"invalidity" in their own work, have asked for better models. 
This situation is clearly illustrated by Grimshaw and D'Arcy 
(18, p. 262). Having observed nonparallel log dose-response 
lines (in violation of the condition of similarity) in their 
pharmacological studies, they suggest the possibility of a 
new index that takes this fact into account. They conclude, 
"It would therefore seem that whilst there are several methods 
available to detect local anaesthetic activity there is not as 
yet a fully satisfactory method for a complete quantitative 
assessment." 
3. Linearity 
In the majority of bioassays, it is assumed that the 
relationship Y = F(z) is linear or may be made linear by 
appropriate transformations of Y and z. A major difficulty, 
as one might suspect, in some exploratory bioassays is that 
of finding transformations (metameters) of the dose and 
response units so that a linear model is appropriate. If time 
and other resources were always available to the extent that 
the form of the dose-response curve could be well established, 
there would be few problems in this regard. However, situa-
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tions exist where such an examination is not possible. In 
some studies, for example, large quantities of test prepara­
tions are screened. The nature of the dose-resonpse curves 
are unknown and only a few dose levels for each preparation 
may be used. The use of any specific parametric models for 
F(z) in such cases may be suspect. 
Finney, (15, p. 162) in 1952, and Bliss, (5) in 1957, 
discuss the use of a quadratic model in cases where a linear 
model appears to be inadequate. Mantel and Hilgar (24, p. 61) 
have considered the effects of using a linear model in bioas­
says when, in fact, F(z) is nonlinear. Their study is 
concerned with the routine screening of drugs with bioassay 
techniques. They point out the fact that, "The existence of 
such nonlinearity could lead to extremely misleading estimates 
of relative potency if straight line procedures were routinely 
used with all data received." In the absence of a parametric 
model, their empirical study resulted in a rule of thumb 
procedure that appeared to work fairly well with a specific 
sigmoidal curve. 
When situations arise where there is little or no theo­
retical basis for a specific dose-response model, one can 
well establish a case for estimators which do not require 
such a model. Such estimators are frequently used in quantal 
response assays. However, as Finney (14) points out, all of 
the standard methods of this type have serious shortcomings. 
For example, some lack procedures for testing the validity of 
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the assumptions, and some require unrealistic assumptions. A 
few specific examples will be discussed in Chapter III. Recent 
studies in this area are by Van Eeden (32), Goldberg (17), 
and Cochran (10). 
The limitations of a mathematical model are determined 
by the validity of the assumptions inherent in the model. 
Three basic assumptions in the standard bioassay models that 
have been pointed out in this chapter are : 
1. monotonicity of F(z) 
2. the condition of similarity 
3. linearity of Y = F(z), where Y is the response 
metameter and z is the dose metameter. 
Assumptions 1 and 2 are prerequisites in all of the standard 
models. Assumption 3 is required of most assay models such 
as in slope ratio or parallel line assays. 
A few examples of situations occurring in the practical 
application of bioassays where the above assumptions failed 
to hold have been cited. The purpose of this thesis has been 
to provide statistical procedures relevant to the consideration 
of these basic assumptions. In Chapter II tests for mono-
tinicity and similarity, which are not based on a parametric 
form of F(z), are described. Chapter III is concerned with 
the development of a distribution-free estimator of relative 
potency in quantal response assays. The derivation of a 
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general model which offers a means of expressing the results 
of bioassays where the condition of similarity does not apply 
is given in Chapter IV. 
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II. BASIC VALIDITY TESTS 
A. Tests for Monotonicity 
Validity tests, in the statistical sense, are significance 
tests of the hypothesis that the observations are compatible 
with the assumptions required by the chosen mathematical model. 
Tests of the hypothesis that F(z) is monotonie, where the exact 
parametric form of F(z) is unspecified, are given in this chap­
ter. Ideally, it would be preferable to test for strict mono-
tinicity, however, the general manner in which the null 
hypothesis must be specified forces consideration of tests for 
monotonicity only. The null hypothesis of monotonicity will 
be accepted unless significant evidence against HQ is observed 
at the dose levels employed. It should, however, be remembered, 
that no information on F(z) between the actual z's used is 
available. 
Van Eeden (31), in 1960, considered a class of tests of 
the hypothesis that k parameters 
9]_, ' * • • ' 
satisfy the inequalities 
®1 — ®2 — ' ' 1 — ®k 
against the alternative hypothesis that at least one value 
of i exists for which 9^ > Although this null hypothesis 
H is appropriate for testing the monotonicity of F(z), the 
alternative hypothesis here is not and leads to difficulties 
14 
as will be shown. 
The situation to be considered may be stated as follows. 
At each known independent dose z^ , there are n^ independent 
observations (i = 1, . . ., k). Let y^ (j = 1, . . ., n^) 
represent an observation at z^ and let 9^ denote the mean of 
the distribution from which y^. is drawn. If at each i, this 
o 
distribution is normal with a known variance a , Van Eeden's 
test criterion leads to use of the statistic d^ = y^+^ - y^ 
ni 
(i = 1, . . k - 1), where y. = ^ ZZ. y• •. A critical 
1 i j=l 1J 
region is determined for each d^ and HQ is rejected if any 
d^ exceeds its critical value. No account is taken of the 
magnitude of k. 
Because of the form of the alternative hypothesis, this 
test obviously has low power against the particular alterna­
tive of a gentle downward trend among the 9^'s. Specifically, 
it may be seen that HQ will not be rejected by this test 
criterion even though y^ > - • • > ? such that 
9l > > 9k provided no d^ is significant. Although this test 
procedure may be appropriate for the given H^, it appears, 
therefore, that it is not appropriate for the general bioassay 
problem as Van Eeden (32, p. 209) has implied. 
A related test procedure was given by Bartholomew (3), 
in 1959. In this case the hypothesis to be tested is 
Ho : ®1 = ®2 = ' ' • = ®k anc* ^ e alternative hypothesis is 
H. : 9-, < 9n < . . . < 9, where at least one of the inequality 
A 1 — Z — — K 
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signs must be a strict inequality. In subsequent papers 
(3, 4), Bartholomew has discussed some properties of his de­
rived test criterion. Although, this is not the hypothesis of 
interest here, it has analogies with one developed in Section C 
which is specifically adapted to bioassay. 
B. The Quantal Response Case 
1. A range test for monotonicity 
The experimental situation may be described as follows. 
Let the number of independent observations n, be the same at 
each independent dose (i = 1, . . ., k). The y^ 
(j = 1, . . ., n) observations at each z^ are assumed to be 
binomially distributed with parameters and n. Let 
y^j = 1 if the response occurred and y^ = 0 if the response 
did not occur. The P.'s are assumed to lie on the dose-
response curve P^ = F(z.), where F(z^) is a continuous non-
decreasing function (the non-increasing case can be treated 
by making certain obvious sign changes). No parametric form 
for the relationship P^ = F(z^) is specified. 
In order to test the assumption that F(z^) is non-
decreasing, the following hypothesis HQ : P^ < P^ < • • . < P^ 
is tested against the alternative hypothesis, : P^ > Pj_+m 
for at least one i and m (i = 1, . . . k; m = 1, . . . k - i). 
An intuitively reasonable statistic for use in such a test is 
A A A 
observed value of max (p. - P•,m), where the symbol over 
all i, m 1 1+m 
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a parameter indicates an estimate of it. Since n is the same 
at each z^, an equivalent statistic is max 
all i, m 
<Yi - Yi+m> 
n 
where = 
j=l 
^ij' ^ i+m 
j=l 
yi+m, j' ^ this quantity is 
not positive it gives no evidence contrary to H and HQ 
would be accepted. In cases where the quantity is positive it 
then becomes necessary to examine its distribution under HQ. 
It can be seen that the use of max (Y- - Y- ) as a test 
all i, m 1 1+m 
statistic leads to a one tailed test, since differences in one 
direction only are of interest. 
Consider the distribution of w = Y„_v - Y_- under the luaX lui n 
special case of the null hypothesis, pi - p2 - . 
= 0.5. A general expression for the probability that the 
range w equals r, when k independent samples each of size n 
are drawn from a binomial population with probability of a 
response equal to P, is given by 
n-r 
Pr(w=r) = y ' 
i=o 
i+r-1 
l+r 
Z- ("ipV3 
J=I 
i+r 
j=I 
k 
Lj=i+l 
i+r-1 
j=i+l 
•  ( 2 )  
The above expression can be derived by considering the prob­
ability that all of the observations fall into the interval 
[i, i+r] where the values of i and i+r are obtained at least 
once. 
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The probability, for a given i, that all of the observa­
tions are in [i, i+r] and that values i and i+r are obtained 
at least once, is Pr {all observations are in [i, i+r]} - Pr 
[all observations are in [i+l, i+r] or [i, i+r - l]J . These 
probabilities are then summed over all i. 
The special case of (2) of interest here is obtained by 
putting P = 0.5. In this case 
k 
P(w=r) = 
" i+r k ' i+r 
ZL(?) - 51 (j) 
J=1 j =i+l 
'i+r-1 k r i+r-1 
2: (?> + 
. j=i _ j=i+l 
k 
(3) 
The use of (3) is illustrated in the following example, 
Given n = 4, k = 4, then 
Pr(w=2) = (i)16 
" i+2 4 !• i+2 4 
H <!' - z: <!' 
J=i . j 
'i+l 4 ' i+l 
T. 
+ 
J=i _j=i+l 
1 
= [11^  - 10^  - 5^  + 4* 
+ 14 10^  - 10^  + 6^  
,+ 11^  - 10^  
(28, 256) 
0.431 . 
5^  + 4^ ] . 
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In theory, the exact distribution of w could be calculated 
for restricted combinations of n and k likely to be used in 
certain types of bioassays, and it would not be a formidable 
task for an electronic computer to obtain the probabilities. 
As an alternative to obtaining these exact probabilities, 
the normal approximation to the binomial, known to be quite 
good when P = 0.5 even in small samples, was investigated. 
Pearson (26) has tabulated some percentage points for the 
Y - Y distribution of the standardized range W = max min 
o 
in samples of size k (k = 1, 2, . . ., 20) from a normal 
population with a known a. Application of the normal approxi­
mation yields the following results : 
Y - Y Y y 
max min = max mm = 
JnPQ -V(n) ( .5) ( .5) 
Y - Y - = W, 
max min _k Jn 
2 
Ymax - Ymin = Ck ^  
It follows, therefore, that in order to obtain the 5 per 
cent and 1 per cent critical points, C, and C, respectively, 
*5 "l 
the tabulated W^'s must be halved. Since the test of interest 
is a one tailed test, the appropriate Wk's are those correspond­
ing to percentage points 10 and 2. Table 1 presents values of 
Ck obtained in this manner. A test of H* against the altér­
ée 
native H. is thus provided by comparing max (Y^ - Yi+m) 
observed in k samples of size n with 
19 
Ck n/n . 
a 
A comparison of the upper percentage points of the exact 
and approximate distribution of w was made for two cases. In 
one case where k = 4 and n = 4, the exact probability that 
w = 4 is .04, while the probability for this event provided by 
the normal approximation is .06. In the case where k = 10 
and n = 4, Pr(w >7) = .036 is the exact figure and the 
approximate probability is .021. The approximation thus appears 
to be reasonable even for such small samples as n = 4. Further 
preliminary numerical investigation suggests that the tail of 
the exact distribution of w is somewhat thicker than that of 
the corresponding approximate distribution. However, from the 
closeness of the approximation, in cases so far examined, it 
appears that use of the test based on the normal approximation 
would be reasonable in most practical cases. As an additional 
safeguard against obtaining misleading inferences, it may be 
noted that the actual null hypothesis here tested is itself 
conservative in the sense that the probability of rejecting 
H , and accepting H^, is greater in the case than for any 
other case under H . This can be seen by noting—that in-a 
case where an equality sign in H' is replaced by an inequality 
of the type that occurs in H , then 
Pr [ max (Y, - Y. ) > C] 
all i, m 1 1+m 
for any real constant C, would not be greater than the prob­
ability of this event under H'. Critical valves established 
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Table 1. Values of C, (a = .05, .01) for the approximate 
a """• 
one tailed range test in binomial populations 
(k) 
Number of 
samples Ck.05 
i—1 o
 
u
 
(k) 
Number of 
samples 
Ck 
".05 
•—
1 o
 
o
 
2 1.160 1.645 11 2.105 2.475 
3 1.450 1.900 12 2.140 2.510 
4 1.620 2.045 13 2.175 2.540 
5 1.735 2.150 14 2.205 2.565 
6 1.830 2.230 15 2.235 2.590 
7 1.900 2.295 16 2.260 2.615 
8 1.965 2.350 17 2.285 2.635 
9 2.020 2.400 18 ,2.305 2.655 
10 2.065 2.440' 20 2.345 2.695 
for P - 0.5 will also, of course, be conservative in the 
above sense if the true value of P is not equal to 0.5. 
An example illustrating the range test uses data taken 
from a study by Carlson (9) in 1963. In an investigation of 
the effects of an insecticide (Co - Ral) on a certain species 
of insects (Hexagenia), the following results were observed, 
where n = 30 at each dose. 
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Dose (coded) Number dead 
1 Y1 
= 4 
2 
Y2 
= 12 
3 
. 
Y3 
= 17 
4 . Y4 
= 21 
5 Y5 
= 19 
6 Y6 
= 23 
7 Y7 
= 30 
The max ( Y. - Y. ) is 21 - 19 = 2, and C-, ns- 4n 
all i, m 1 1+m 7' 'Ub 
= 1.90 J30 = 10.4. The hypothesis that Pj_ < P2 < • . . < Py 
is accordingly accepted, in this case. 
It might be remarked in passing that the methods described 
in this chapter for determining significance levels of the 
range in samples from a binomial population may have applica­
tions in making "multiple range tests" in other types of 
analyses based on proportions. In fact, the idea of deter­
mining which P^'s are significantly different, by comparing 
A. A 
P^ and Pj (for all i, j) with the percentage points for the 
distribution of the range, is directly analogous to Tukey1 s 
(30) multiple range test. 
2. An alternative test for monotonicity 
The range test for monotonicity is obviously of low power 
with respect to certain specific alternatives under This 
is a result of the generality of the hypotheses and the fact 
that the "worst" possible case under H had to be considered. 
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Another criticism of the range test is that the test statistic 
is based only upon the maximum discrepant observation, and 
does not utilize all of the evidence against HQ unless 
> Y^+^ for only one i. If Y. > Y^+^ for more than one i, 
it is desirable to have a test which uses more of the informa­
tion available. An.appropriate procedure based initially on 
that suggested by Bartholomew (3), is derived in this section, 
and although it is not clear whether or not the test has opti­
mum properties, the technique appears to give meaningful 
inferences. 
Suppose, as before, that results of k independent bino­
mial samples, of n trials each, are given, where the number 
having responded at trial z^ is Y^, the hypothesis 
Pi < P% < . - . < Pk ' 
is to be tested against 
"A/ Pi < ?i+m 
for at least one i and m (i = 1, . . ., k) (m = 1, . . ., k-i). 
The maximum likelihood estimates pf of the , under HQ, 
are the same as the unrestricted maximum likelihood estimates 
of p., namely Yi, if Y, < Y0 < . . . < Y, . If, however, for 
v 
'1 ^ '2 ' ' " k' 
n , 
alue(s) of i, Y- > Yi+1, then in order to obtain the Pi's,i 
the i+h and i+l+h samples are averaged giving pf = pf+1 
= 
Yj + Yi+1. Starting with Y, and progressing to Yj_, this 
2n 
procedure is continued, an averaged p being treated as a 
single observation (weighted by its total n), until estimates 
which fulfill the condition: 
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P]_  ^P2 —•••£. Pj^  
are obtained. This method will be illustrated later in a 
numerical example. 
As Van Eeden (32) has remarked, the estimates obtained by 
this pooling technique are the maximum likelihood estimates of 
the Pi's under HQ. This fact can easily be seen by noting 
that if > Pj_+j_) the maximum of the likelihood function 
under HQ occurs at the boundary of the feasible region, 
Pi = Pi+1 = P, since. 
L  
=  ? i \ n i  Y i  '  Y l + 1  
= pYi+Yi+lQni+ni+l"^Yi+Yi+l^ 
The expected number of responses at dose z^, under HQ is 
thus estimated by pfn and the usual chi-square goodness of fit 
criterion applied in this case leads to the following test 
statistic 
X =72[Yi-Pi'n:i2 + )"]2. (4) 
i+1 p^n (l-pT)n 
If r (<k) groups were obtained by the pooling process 
described, then there are r different pf1 s. It can be seen 
that contributions to the calculated value of X are made only 
by the pooled groups. The calculated X is based on k - r 
degrees of freedom and, if no account were taken of the pool­
ing procedure, this statistic would, be asymptotically 
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2 distributed as % k-r' under the special case of the null hy­
pothesis, HQ: P-^ = ?2 = . . . = . This can be seen by 
noting the results of Bartholomew (3, p. 41) where it is shown 
that if the Y^'s are normally distributed with a common 
2 
variance, a , then estimates obtained by the pooling procedure 
described may be treated as though they were independent. 
In order to derive the approximate distribution of X|h^, 
allowance must be made for the probability of obtaining r 
different groups out of k initial groups by the described 
amalgamation process. Let P(r, k) denote this probability. 
The approximate probability that a calculated value of X will 
exceed a given XQ may therefore be written as 
k-1 
= ZZ. k)Pr(x^  > kg), (5) 
r=l k_r 
or k-1 CO 
r=l 
Pr(X > X ) = P(r, k) T )d%^ 
J k-r k-r. (6) 
X 
o 
In 1959, Miles (25) showed that P(r, k) = js^l/k.', if 
the groups are equally weighted, where s£ is the Stirling 
number of the first kind. A table of these numbers may be 
found in Miles's paper. The distribution in (6) is analogous 
to the distribution defined by Bartholomew (3) in 1959. 
However, because a different hypothesis is of interest here, 
the degrees of freedom associated with the chi-square terms 
are not the same in (6) as in Bartholomew's As a result 
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the distributions are not the same. 
The upper 1 and 5 percentage points for X for certain 
values of k a: e 2. These points were calculated 
from (5) using a table of the Stirling numbers and the distri-
2 bution function of % as tabulated by Pearson and Hartley (27). 
Interpolation was used to obtain the third significant figure 
} 
of the percentage points and, as a result, there may be an 
error of one unit at that figure. The significance of a 
calculated X as given in expression (4), may then be tested 
by the use of Table 2 for the specified values of k. This 
statistic is appropriate for testing , which again can be 
seen to be conservative in the sense that for any other ' 
under H , 
Pr[X > XjH^] > Pr[X > XjH^']. 
Table 2. Approximate percentage points for X 
k Pr(X > X^) = .05 Pr(X > X-J = .01 
3 4.61 7.73 
4 6.19 9.58 
5 7.69 11.3 
6 9.10 13.0 
8 11.9 16.1 
10 15.0 19.1 
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As a simple illustration of the calculations involved when 
the X criterion is used to test for the monotonicity of F(z), 
data from Carlson (9) used in the previous example have been 
altered. Suppose that (where n = 30, at each x) the following 
observations had been made. 
Dose (coded) . . - ..Number dead 
1 Y^ = 7 
2 Yg = 5 
3 Yg = 15 
4 Y^ = 21 
5 Y5 = 21 
6 Y6 = 18 
Since Y^ > Y^, these groups are averaged, and since 
Y4 > Y5 + Y6 = 19.5, Y4, Y^ and Y^ are averaged. Yg is then 
less than Y4 + Y5 + Y6 = 20. Since Y-, > Yn, these two are also 
3 Z 
pooled. The pf1 s are therefore 
p' = 6 = .20 pu = 20 = .667 
1 30 ^ go 
p' = 6 = .20 p^ = 20 = .667 
2 30 ^ 30 
p' =15= .50 p& = 20 = .667 
3 30 30 
where p-j% < p^ < . . . < p^. The calculated value of X in this 
case is 
X = (7 - 6)2 + (24 - 23)2 + (6 - 5)% + (25 - 24)% 
6 24 6 24 
+ (21 - 20)2 + (2Q _ g)2 + (21 - 20)2 ^  - 9]2 
20 10 20 10 
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+ (22 - 20)2 + (go - 18)2 
20 10 
= 1.32 
This value is less than the significance levels for k = 6 and 
the hypothesis of monotohicity of F(z) is accordingly accepted 
at a = .05. 
C. The Quantitative Response Case 
1. A range test for monotonicity 
Let the number of observations, n, be the same at each 
independent dose z^ (i = 1, . . ., k). Let the 
Yjj(j = 1 ; . . ., n) observations at each z^ be normally 
distributed with mean E(y^ j ) = and a common but unknown 
o 
variance a . The Y.'s are assumed to lie on the dose-response 
-L . --
curve Yjj = F(z^) . 
It is desired to test the hypothesis HQ: Yn < Yp < 
• • • < \ against the alternative hypothesis H^: Y^ > 
Y. (i = 1, 2, . . ., k; m = 1} 2, . . ., k - i) for at least 
m 
one i and m. As with the quantal response case, consider the 
special case H^: Y^ = Y^ ~ . • . = Y^ under HQ. To test HQ 
against H^, tables of the studentized range may be used. The 
criterion for a test of size a is to compare 
m a x  (Vi - Yi+m) with 1 q2a) k(n.1) 
sj n 
where q is tabled by Pearson and Hartley (28), and s is the 
usual "within dose" estimate of a, based on k (n-1) degrees 
of freedom. Since a one sided test is required in the present 
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situation, the 2a percentage points of q must be used; how­
ever, only the upper 5 and 1 percentage points for the 
studentized range are given in standard tables and the signif-
cance tests must, at present, be made at the 2.5 and 0.5 
percentage points. Again, this test is conservative in the 
sense that the probability of rejecting , and accepting 
is greater under than for any other case under HQ. 
2. A basis for an alternative test for monotonicity 
Suppose that there are n^ observations at each independ­
ent dose (i = 1, . . ., k). Let the y^j (j = 1, . . ., n^) 
observations at each z^ be independently and normally distrib-
2 
uted with mean and a common unknown variance a . It is 
assumed that the Y^'s lie on the curve Y^ = F(z^). Let 
k 
2L ni = n-
i=l 
It is desired to test the hypothesis, 
Yi < Y% < . . . < Y^ 
against the alternative 
H^: Y^ > Y^+m, for at least one i and m 
( i — 1, . . ., k) (m = 1, . . ., k-i). 
The likelihood function in this case is 
L = (27T)-n/Wn/2. 
o 
The maximum likelihood estimator for a under the condition 
that Y^ < . . . < Y^, as indicated by Bartholomew (3), is 
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k n. 
o 2 
is s - 1 y y (y.- - m.) where the m. are obtained by the 
o — — c.— 1J 1 1 
' k=l j=l 
following pooling process. That is, = y^, if y^ < y^_^, 
whereas if y^ > Yj_+j_5 then nrv = = 
"i "i+1 
Yij + ZZ Y ( i+1 ) j 
j =1 j-1 . Starting with y, , this process is 
ni + ni+i 
continued until mn < m„ < . . . < m , r< k. The maximum like-1 — 2 — — r — 
o 
lihood estimator for a under can be seen to be the same as 
its unrestricted estimator, 
k=l j=l 
The likelihood ratio principle yields 
X = fo_ = fA. 
Thus 
k n^ 
2/n (Yij " "i'2 
X Z/n = k=l j=l. 
k n. 
ZLZ-^ij - vt)2 
i=l j=l 
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k n. 
ZZICtVij - ?i)2 + (Yi - m,)2] 
= k-1 j=l 
1 2 
k n 
i=l j=l 
k 
- w - - m i 2 1 v '1 = 1 + ZI n. (y. )i=l 
k n. 
IlZ^ii " vi) 
1 2 
ij
1=1 j=l 
This leads to the consideration of 
r 
Z>i(Yi - mi)2 2 
= 1 = sb , where 
(r-l)s* s2 
k n. 
Z. ZSin - n) 
1  
-  > 2  
o 1J 
s2 = j_i 
n-k 
'The distribution of under HQ can be shown to be closely 
related to Bartholomew's F^ criterion, the only difference being 
in the degrees of freedom of the F ratio. It has been shown 
(2) that 
k 
Pr(Fk > Y) =ZLp(r' k) Pr[Fr_1? n_r >y], 
2 
and it can similarly be shown that 
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k 
Pr(V > ï) =HP(r, k) Pr[Fk.r) n„r > y] 
2 
where P(r, k) is the probability of obtaining r almalgamated 
groups by the pooling procedure out of k groups. Percentage 
points for the distribution of \' are, however, difficult to 
obtain and have not been tabulated. At the present time, the 
one tailed range test would be the recommended procedure for 
testing H against H. in quantitative response assays. 
D. Investigations of Similarity 
1. Preliminary graphical investigation of similarity 
The plotting of data on a graph as a first step in a 
statistical analysis is frequently of value in deciding on an 
appropriate method of analysis. Reasonable models and/or 
possible useful transformations may sometimes be seen more 
easily by this technique. A common problem in the usual 
analysis of bioassays is the determination of an appropriate 
response metameter ,(Y) which yields a linear relationship 
with the dose (z), or log dose (x). In assaying preparation 
S against preparation T by the usual methods, a Y must be 
found such that either 
YS G + PgZg 
= a + P-j -Zj  (slope ratio model) (7) 
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or 
Ys = og + ;xg 
"N I 
Yy = aj + pXy 
(parallel line model) (8) 
are reasonable models to be employed. 
For the above, or any^other models based gg similarity 
to be appropriate, Fg(Zg) and F^(z^) must be of the same 
functional form, that is Fj( z^.) = Fg(pz^), for all z^, Zj. It 
may be difficult to tell whether this condition holds or not 
simply by looking at the data or even a plot of the data. If 
the condition definitely does not apply, then there is no 
need to search for a response metameter that will allow use 
of (7) or (8). A quick approximate check on the existence of 
similarity may be made by the following graphical procedure. 
The observed responses are plotted against dose (z) 
for both preparations S and T. Using a French curve, a smooth 
monotonie curve is drawn by eye through the points for S and, 
independently for T, as shown in Figure 1. If these curves 
represent the dose-response relationships fairly well, a graph 
of equally effective doses of Zg and z^ may be obtained. An 
estimate of the zg which is equivalent (in its ability to 
produce the response) to a specified Zj, is the Zg which 
corresponds to the response Y (z^). A curve approximating the 
relationship between equally effective doses may be obtained 
by plotting the z-'s corresponding to equally spaced 
Y 
6 
2 
Z. 
PI 
2 3 
ZT 
w 
w 
Figure 1. A graphical investigation of similarity 
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Zy's, as shown in the right hand graph in Figure 1. A linear 
appearance of this curve would tend to support the hypothesis 
of similarity, the slope of the line zg = pz^ being a rough 
estimate of relative potency. If however, this relationship 
is decidedly non-linear then the indication is that similarity 
does not apply, in which case no transformations of the data 
will allow use of a slope ratio or a parallel line assay model. 
In this case, although not of the simple z^ = pZj form, it 
might be desirable to find an appropriate model for the rela­
tionship and estimate its parameters. 
2. Tests for similarity 
If the condition of similarity applies, then, as dis­
cussed in Chapter I, relationships may always be expressed as 
Yg = Fg(xg) and = Fy(x_ - M) where x = log dose z, and M 
is log p. In the usual parallel line assay analysis, an 
appropriate linearizing response metameter is employed and 
the test for similarity is then based on deviations from the 
parallel line model. The following general test for similar­
ity may be made (if monotonicity of the two curves is assumed) 
without assuming a specific form for F(x), by using the range 
tests given in Sections B and C. 
Let there be n subjects exposed at each of the k doses 
of the standard preparation S and the k^ doses of the test 
preparation T. Under the hypothesis of similarity, the two 
observed log dose-response curves approximate to the same 
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monotonie function apart from their being horizontally dis­
placed by an unknown amount M. Suppose that the observations 
on both preparations are amalgamated, by a trial horizontal 
translation of the observations on one of the preparations, 
to approximate a single monotonie function. Suppose, also, 
that after such a translation, the response observed at each 
dose is subtracted from the responses observed at every dose 
on its left. The maximum value obtained out of all differences 
taken in this manner may be noted. The particular transla­
tion (s) which yields the minimum value of this maximum dif­
ference is(are) the optimal translation(s) in this special 
snese. If, however, this minimum value exceeds the appro­
priate critical value of the range test for monotonicity, 
for kg + k_ samples of size n, then it seems reasonable to 
reject the hypothesis that the two sets of observations arose 
from monotonie functions of exactly the same shape, since 
combination of all observations, even in this optimal manner, 
would not allow acceptance of the hypothesis of monotonicity. 
The following numerical example of this type of test is 
based on hypothetical data. Suppose that in a quantal response 
assay with equally spaced log doses (on the same scale) where 
50 subjects were exposed at each dose, the number having 
responded at each dose were 
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Ygl = 5 Y^  = 4 
Ygg = 38 Y^ g = 20 
YS3 = 45 Y^ s = 25 
The minimum value of the maximum difference (taken in 
the manner described), that can be obtained by a horizontal 
translation of the observations, is 13, as illustrated in 
Figure 2. The appropriate value of obtained from 
Table 1 is 1.83. Since 13 is greater than 1.83 J3Ô = 10.03, 
the hypothesis of similarity would accordingly be rejected at 
a  =  . 0 5 .  
As would be expected, the hypothesis of similarity is 
rejected when a standard parallel line probit model is fitted 
to this data. Finney (15, p. 471-472) suggests procedures 
applicable in situations where tests of linearity are signif­
icant, but the assay is considered invalid, in any case, if 
similarity cannot be accepted. Other possible alternatives 
in such cases are discussed in Chapter IV. 
37 
50 
40 
30 
20 
10 
o STANDARD PREPARATION (S) 
•  TEST PREPARATION (T) 
_L 
ORIGINAL 
S2 S3 
T| T2 
OBSERVATIONS 
T3 
50 
40 
30 
20 
10 
o 
_L I _L 
S2 
T, 
S3 
To 
AN OPTIMAL TRANSLATION OF THE OBSERVATION ON T 
Figure 2. Translation of the observations on T 
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III. DISTRIBUTION-FREE ESTIMATION OF RELATIVE 
POTENCY IN QUANTAL RESPONSE BIOASSAYS 
A. Some Distribution-Free 
Estimators of Relative Potency 
Several methods have been developed for the estimation 
of the LD-50, that is, the median of the tolerance distribu­
tion, in quantal response assays. In some of these methods 
(e.g. probit, logit), the assumption is made that the toler­
ance distribution is of a known parametric form. Other 
methods, referred to by Finney (14, p. 364) as, "... the 
objective yet rapid methods . . do not require specifica­
tion of an exact functional form for the tolerance distribu­
tion and are distribution-free in that respect.— An estimate 
of the relative potency of two preparations may be determined 
by the ratio of two such LD-50 estimates (under the hypothesis 
of similarity). These distribution-free estimators are usual­
ly easy to compute and, although their properties are often 
difficult to evaluate, the methods have found application in 
many practical cases. 
One of the simplest of the distribution-free techniques 
for estimating relative potency is that of linear interpola­
tion. In this case, an estimate of the LD-50 is obtained for 
both the test and standard preparations by linearly interpolat­
ing between the two observed response percentages which bracket 
the fifty per cent points. This procedure has been recommended 
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by Doudoroff rt al. (13) for use in toxicity studies on 
fish, for example. An obvious objection to this general 
method is, as Finney notes (14, p. 343), that it only uses 
part of the data (two doses from each preparation). 
Other distribution-free techniques for providing esti­
mates of the LD-50 and relative potency, such as the Dragstedt-
'Behrens, Reed-Muench, and Spearman-Karber methods, are dis­
cussed by Finney. In this review of the advantages and dis­
advantages of these and other methods, Finney (14, p. 364) 
states, with some reservations, that the Spearman-Karber 
procedure is perhaps the best of the objective yet rapid 
methods available for estimating relative potency and recom­
mends that the Dragstedt-Behrens and Reed-Muench techniques 
be completely abandoned. 
1. The Spearman-Karber estimator 
Let n subjects be exposed at each of k doses of a 
preparation, and let y. denote the number having responded 
at dose i. If the log dose levels (x.) are x^, x2 = X1 + ^ ' 
. . . , 
= xj_ + (k-l)d, the Spearman-Karber 'estimator of 
the LD-50 is 
k-1 
x = Pi(x^-ld) + ^ lUi+ld) (pi+1 - p±) + (l"Pk)(xk + Id) 
2 i=l 2 
k 
= x, + Id - d ^ >~ p. , where pi = y^. 
2 i=l ~n~ 
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A symmetrical tolerance distribution is assumed, in 
which case the mean equals the median. Another necessary 
assumption is that the probability of a response is zero at 
all doses to the left of - d, and that the probability of 
a response is 1.00 at x, + d and higher doses. As Finney 
(14, p. 347) points out, the latter assumption may not be 
fulfilled in many situations. In such cases it is therefore 
worthwhile to consider alternative estimators. 
B. An Alternative Distribution-Free Method for the 
Estimation of Relative Potency 
As has been previously pointed out, under the condition 
of similarity, the log dose-response curves corresponding to 
the standard and test preparations have exactly the same shape, 
but are separated horizontally by an unknown distance M. In 
the quantal response case, for example, this implies that 
Fg(Xg) = FT(xs - M), 
where Fg and F^ are the distribution functions corresponding 
to the tolerance distributions for preparations S and T 
respectively. The problem of interest for bioassay purposes 
is that of estimating M, the horizontal displacement of the 
two monotonie curves, without assuming a parametric form for 
F. 
It is rarely clear what criterion should be used for the 
determination of a distribution-free estimator. One possible 
criterion which might be considered in this case is the 
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"average" horizontal distance between the two observed log-
dose response curves over the observed response range common 
to both curves. The problem of defining the average distance 
then arises. One such average may be obtained by an extension 
of the simple linear interpolation technique described in 
Section A, as follows; 
Suppose that in a quantal response bioassay there are n^ 
subjects exposed at each log dose, xg^(i = 1, 2, . . ., kg), 
of the standard preparation S and each log dose, xyj(j = 1, 2, 
. . ., k.p) , of the test preparation T. Let xg^ and . be 
equally spaced. Denote the number having responded at xg^ by 
y^ and similarly y. at x^., and let the corresponding propor­
tions be p. = ^i and p. = ^j. 
"I J ^ 
An estimate of the value of x_ which corresponds to an 
observed p_^ may be found by linear interpolation between the 
two x^j's which correspond to the two Pjj's (if there are such) 
which bracket the observed p_^. The distance between an xgi 
and the x_ estimate thus obtained provides an estimate of M. 
Estimates of M may be made in this manner for all values of 
Pg^ which lie in the range of observed responses common to 
both preparations, and similarly for all values of p^j in the 
common response range. These separate estimates of M are not 
all independent, but even so the average of all of the esti­
mates that can be obtained in this way provides an estimate 
of the average horizontal distance between the two response 
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curves. 
1. Numerical example 
Data for the following example is taken from an example 
used by Finney (14, p. 342) in which estimates of the rela­
tive potency computed by various methods were compared. The 
results of a quantal response assay were as shown below. 
Standard preparation Test preparation 
coded number number number number 
log dose exposed killed per cent exposed killed per cent 
-1 94 21 22.3 96 5 5.2 
0 98 38 38.8 96 20 . 
00 o
 
CM 
+1 96 64 66.7 97 56 57.7 
These results are illustrated in Figure 3. The three 
horizontal lines in the figure are estimates, obtained in the 
manner described in this section, of the distance between the 
two response curves. The three calculated values are 
1 + 22.3 - 20.8 =1+1.5 = 1 + .041 = 1.041 
57.7 - 20.8 36.9 
38.8 - 20.8 - 18.0 = 0.488 
57.7 - 20.8 36.9 
66.7 - 57.7 = 9.0 = 0.323, 
66.7 - 38.8 27.9 
and the average of the these three estimates is 
•M = 0.617. 
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Figure 3. Results of a quanta1 response bioassay 
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2. Some empirical comparisons with other methods 
It is difficult to compare distribution-free estimators 
other than on an empirical basis, as Finney has done, since in 
most cases their biases and variances are not known. In 1961, 
Brown (6) discussed these properties for the Spearman-Karber 
estimator in a hypothetical experiment in which an infinity 
of dose levels were available. A formula for the variance and 
bounds for the bias of this estimator are available only in 
the case when complete coverage of the response curves are 
obtained. This is not a common situation in bioassays. No 
formulas for the variance or bounds for the bias of the 
alternative "average distance" method discussed in this chapter 
are yet available. Some preliminary investigations are given 
in Appendix A. 
As a partial evaluation of the average distance estimator 
it is of interest to compare estimates obtained by this method 
with those obtained by some other methods, both distribution-
free and parametric, in some specific bioassays. 
a. Example 1 For the data in the previous numerical 
example, Finney (14) has calculated estimates of M by several 
methods, five of which are shown below along with the average 
distance estimate. 
Finney (14, p. 364) indicates that there is little doubt 
that the true value of M lies close to the results obtained by 
the probit and logit methods, and points out that all of the 
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A 
Method M 
Dragsted-Behrens 0.394 
Reed-Muench 0.401 
Spearman-Karber 0.441 
probit 0.662 
logit 0.634 
average distance 0.617 
distribution-free estimates were far too small. The Spearman-
Karber estimate given was qualified in that it was obvious 
that one of its basic assumptions, previously discussed in 
Section A, was not valid. The estimate of M (0.617) calcula­
ted by the simple average distance method can be seen to be 
much closer to the probit and logit estimators, in this 
particular example, than any of the distribution-free estimates 
calculated by Finney. 
b. Example 2. Burn et al. (8, p. 137) 
Standard Preparation Test Preparation 
log number number per log number number per 
dose exposed killed cent dose exposed killed cent 
.602 20 2 10 .778 20 7 35 
.778 20 16 80 .954 20 19 95 
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The estimates of M (log p) in this case , as obtained by 
three different methods are 
average distance method 
A  
M = 
-0.122 
Spearman-Karber M = -0.106 
probit 
A  
M = 
-0.104 
c. Example 3. Burn et al. (8, p. 145) 
log 
dose 
Standard Preparati. 
number number 
exposed convulsed 
on 
per 
cent 
log 
dose 
Test Preparation 
number number 
exposed convulsed 
per 
cent 
0 12 1 8 0 12 1 8 
1 24 8 33 1 24 16 67 
2 24 15 62 2 24 22 92 
3 10 8 80 3 10 10 100 
Estimates of M for the above assay as provided by three 
different estimators are 
A  
average distance method M = 0.888 
Spearman-Karber M = 0.840 
A 
probit M = 0.959 
In the last two examples, there is little difference 
between the Spearman-Karber and the average difference esti­
mates. 
The latter method does not require the assumption of 
symmetry nor the assumption that the entire response range 
be covered by the doses, which are necessary assumptions in 
the Spearman-Karber estimation technique. The closeness of 
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the approximation to a response curve, by a series of straight 
lines connecting the observed percentages, is probably the 
major factor in determining whether or not the average distance 
method will give a reasonable estimate in a particular bioas­
say. The choice between the methods will depend upon which of 
the above assumptions appears to be the more reasonable in 
any specific situation. 
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IV. SOME GENERALIZED BIOASSAY MODELS AND METHODS 
A. The Condition of Similarity 
As stated in Chapter I, the condition of similarity 
requires that the test preparation (T) must behave as though 
it were a dilution (or a concentration) of the standard 
preparation (S) in a diluent that is completely inert with 
respect to the response used. This implies that the ratio 
of ëqually effective doses p = ^ S is constant, within the 
ZT 
range of experimentation. The relationship between the two 
response curves can therefore be written as 
Ft(zt) = Fs(pzT). 
The truth of the assumption of similarity (analogous to 
the assumption a lack of interaction between treatment effects 
in the analysis of variance) allows the relative potency, of 
S with respect to T, to be expressed as a single number with­
in the range of observations. This condition is, therefore, 
of obvious convenience for the concise presentation and appli­
cation of the results of a bioassay. Validity tests for 
similarity are, in fact, made as part of the statistical anal­
ysis when the standard slope ratio or parallel line assay 
models are employed. Cases frequently occur, however, when 
the assumption is violated and there is then no specified 
standard procedure for analysis available. Another difficulty 
which may arise when the number of observations is small is 
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that the usual validity tests may not be sufficiently power­
ful to detect any such invalidity except in extreme cases. 
Correspondingly erroneous inferences are, therefore, possible. 
The need for a suitable procedure for cases where the 
assumption of similarity breaks down is further evidenced by 
the lack of uniformity in some of the instances which have 
been published, as shown below. 
1. Ing, et al. (20, p. 90) proposed to provide an 
average relative potency estimate over a wide 
range of doses. 
2. Gibbs, et al. (16, p. 408) computed an estimate 
of log p at the 50 per cent level with the 
qualification that, ". . . these ratios, although 
invalid, are nevertheless useful approximations . . ." 
3. Grimshaw and D'Arcy (18, p. 262), in 1960, 
emphasized that there is no adequate method for 
"quantitative assessment" in this situation. 
Two other published examples are by Bulbring and Wajda (7) 
and David and Fellowes (12). In all of the above studies 
linearity of a response metameter Y with log dose was noted, 
but the lines for different preparations were obviously not 
parallel. 
It is the purpose of this chapter to show that methods 
for providing a " quantitative assessment" of two preparations, 
S and T, in just such situations can - be obtained. 
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Attention has been restricted, in the first instance, 
to linear and quadratic dose-response models, since these 
appear likely to be the most common and important cases. 
B. Relative Potency as a Function of Response 
One method that could be used to present the results 
a bioassay when there is a lack of similarity would be to 
express relative potency as a function of the response Y. 
In this manner an estimate of the ratio of equally effective 
doses as a specified response level can be obtained as will 
be shown for linear log dose-response relationships. 
Suppose that Y = 0Cg = (3^Xg and Y = + P^x^ are appro­
priate for the log" dose"-response relationships, where 
x = log dose, x_ and are coded to be zero, and the usual 
Gauss-Markov conditions hold. For a general response level 
Y , say, the logarithm of the ratio of equally effective doses 
may be expressed as x^ - x^. Thus 
M(Y) = log p (Y) = Xg - Xj 
= Y - Gg " Y " aT 
_ Pt(Y - ag) - Pg(Y - aT) 
PS^T 
= PTY " ^ TaS " PSY + ^SaT 
Ps^T 
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T HS Y, (9) 
which may be written as 
A + BY. (10) 
The corresponding relative potency would be 
p(Y) = 10 A+BY 
assuming 10 is the base to which the logarithms were taken. 
Estimators for A and B can be obtained by substituting 
straight lines to the two sets of data independently. Equa­
tion (10) could thus be used to estimate M for a given value 
of the response, Y . 
It can be seen in expression (9) that if = (3^ = j3 , 
then 
a constant for all Y. It thus appears that the standard' 
parallel line assay model is simply that special case of (9) 
for which, under the condition of similarity, In 
this case, a set of parallel lines is fitted to the data and 
the appropriate parameter estimates are substituted in (9) to 
estimate M. 
If the errors about the linear regression models are 
n 
assumed to be NID ( o, cr ), the approximate variance for 
M(Y ) may be found by using the approximate formulas for the 
ag, bg, a^, b into (9) where these are the usual best linear 
unbiased estimators of ag, and , obtained by fitting 
M(Y) = xc - xT = aT " aS = M, 
b l p 
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variance of a ratio of two variables (when the coefficient of 
variation of the denominator is small.) Thus 
Var M(Y ) = Var (Yo " aS) + Var (Y ~ aT) . 
b. b 
T 
where 
Var (Yo " aS) = (Yo " aS)2 
(Y0-as)2 b| 
and 
Var (Yo " aT) = (Yo " aT)2 
2 
T 
2 
+ °bT 
L(Y0~aT^ bi 
Therefore, 
Var M(Y^) , 4< 
+ <yo-as'2< , bT<+(Yo-=T'2< 
S + T 
b 4 )T  
^I'a^Vag)2^] + 4tbT%+< 
44 
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T 
bi+(vas>2 
n, + bs 
bT+^Yo~aT^ 
n 
T Zx 
T 
bs4 
2 
a ? 
<.«: 2 _ 2 _ 2 1 X 0 g Oy 0" • 
A similar treatment of the slope ratio assay case can be 
made. Suppose that Y = ctg + Pgzg and Y = a^. + Pjzj are valid 
models for the dose-response relationships where z is the dose 
and the Gauss-Markov conditions apply. The ratio of equally 
effective doses as a function of Y may be expressed as 
p(Y) = = (Y~gS)/(1~aT) 
7  R _ /  R. . .  
Y- . 
"T 
= & 
l^s )te) 
T 
(11)  
It can be seen that if ag = a^., then expression (11) 
becomes 
p(Y) = fs = = p, 
"T ^5 
a constant for all Y. The ordinary slope ratio assay model 
is, therefore, the special case of (11) for which ag = a^ .. 
The requirement that ag = is thus seen to be equivalent to 
the condition of similarity in this situation. 
Estimates of the parameters may be obtained from the inde­
pendently fitted regression lines, and a value of p(Y ) may be 
estimated for a specified Y by the Equation (11). Under the 
same error assumptions as before, an approximate formula for 
the variance of p(Y ) may be obtained. Thus 
in 
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T 
2
'v^2  
Yo"aTJ 
h2 2 -a ^2 2 
S o S abs-2bg(Yo-ag)cov(as,bg) 
,2 2 _=, t2 2 
+ T craT+^ o T' abT-2bT(Y0-aT)cov(aT,bT) 
T Yo"aS\ 
^ 
Yo~aS^ 
n, 
2 
T 
bl'Yo"aT' 
- 
2bS^Yo~aS^ 
^
zs~zs^ 
Z(Zg-Zg) T 
2 
bs(Yo-as)' 
+ 
bT + ^Yo"al^ - 2bT(Y0"aj)Zy 
n, 
_T o T 
2(Zt-Zt)' 
T 
bT(Yo-aT>2 
An expression of the relationship between p and Y may not 
be the best method of presentation of the results in situations 
where similarity does not hold. Another possible procedure is 
discussed in the next section. 
C.. Equivalent Log Dose Relationships 
1. Fg(xg) = aQ + PqXq, Ft(xt) = aT + p S S T T' T 'T T 
An alternative method, which might prove more convenient 
in some circumstances than expressing p as a function of 
response, would be to obtain an estimate of the functional 
relationship between equivalent (in their ability to evoke the 
response) doses of preparations S and T. Suppose that 
Y = Œg + PgXg and Y = aT + p^x^., where x = log dose z. Upon 
56 
equating these two functions, it follows that 
aS + ^ SXS aT + ^ TXT 
and 
Xg = aT ~ as + ^TXT (12) 
(13) 
which may be written as 
Xg = C + DXy. 
It can be noted that in terms of the z's, zg = ^-zj 
(14) 
in this 
case, where C = log K. 
Equation (14), therefore, expresses the linear relation­
ship between equally effective log doses of S and T. The 
usual linear regression estimators a^, b^, ag, b_ for parameters 
Gy, , as and Pg, respectively, may be obtained by independ­
ently fitting the two linear models, where the response errors 
2 
about both lines are assumed to be NID(o, a )• These esti­
mates may then be used to estimate parameters C and D in (14). 
a. Reduction to usual model If {3^. = [3g = (3, then 
expression (13) reduces to x = aT _^_s + x^, and 
As before, the usual parallel line model is seen to be a 
special case of (13) when the condition of similarity is ful-
Xç - x_ = aT~aS = C. 
b l p 
(15) 
filled. 
57 
For a given value of x^, say b. Fiducial limits 
Xg_, the equivalent (in its ability to produce the response) 
Xg, say xQg, may be estimated by 
x 
"oS 
= 
aT " aS bTXoT' 
as shown in Equation (12). The fiducial limits for x 
oS may 
be obtained by a suitable adaptation of Fieller1 s theorem 
(see e.g. Finney (15, p. 27)). 
Suppose that, in a quantitative response assay, there are 
observations available for preparation S, and n^ observa-
2 tions available for preparation T. Suppose also that ag 
a . Let the variable xQg, for a given xnT, be defined 
T oT 
as the solution of (12). Let a variable u be denoted by 
u ag + bgX^g - bT*oT" 
The expected value of u then is E(u) where 
E(u) = as + j3gxoS ~ ai ~ PjxoT = 
The variable u is normally distributed with variance V(u) 
given by 
v(u) = v(ag) + XggV(bg) + v(a^) + Xg^V(b^) + 2x^gCov(ag,bg) 
+ 2xoTCov(aT,bT) 
1 + 1 + ^xoS"XS^2 + ^xoT~xT^ 
n, n. T Z(xs-xs) S(xT-xT)' 
2 2 
Upon replacement of a by its pooled estimate s it can 
be seen that 
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(ag + bgX^g T b T x o T )  Vtn' 
s\l 1 + 1 + (*oS " XS^ + (xot~ xT) 
"S "T Z(xg - Xg)2 Z(x^- x^.)2 
where N is the degrees of freedom upon which the calculation 
2 
of s was based. This expression may be used to determine the 
values of xQg which correspond to the appropriate significant 
t values. Thus 
(ag + bgXgg 
2 
= t2, 
1 + 1 + (*oS "" + (*oT " 
2 
n, n 
T Z(Xc - x<)2 Z(x^ - x^.)2 
'S S' 
where t is t with N degrees of freedom. By expanding the 
above expression and collecting terms, a quadratic equation 
in x r is obtained : 
> oS 
2 t2s2 
2(Xq-X) 
xoS + 2 
2  2 -
-S- + bs^aS aT bTXoT^ 
z
^
xs~xs^ 
2 2 2 
+ (as - aT + bTxQT) - t s 
1 + 1 + S 
^T 
+ (xqt " xj) 
Z(xT - xT)' 
= 0. 
'oS 
The solution of a quadratic FxQg + ^ xoS + ^  ~ ® maY be 
written in the form 
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In this case, 
_G 
2F 
x°s = "ê±1\ (G/2) 
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x„ + bs'aT + bT XoT C
O 
1 >. 
FbS t2s2 
2(xs-xg) 
and 
(Gp - FH = 
2 ~ 
b$]XS + bS^S aT bTXoT 
il(xg-x)2 
bs ' t2s2 
Z(xg-x^)^ 
(-bsxg + yg - aT bjx0j) 2 
- t2s2 ( 1 + 1 + XS +  ( X O T ~ X T )  
"S "l Z(xg-xg)2 Z(x^ -x^ .)2 T T; 
b:- ^2 
SCxg-Xg) 
1 + 1 + ^ xoT_xT^ 
"l Z(x^.-x)2 
t2s2 
+ t2s2 (yS aT bTxoT^ . 
Elxg-Xg) 
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Thus, 
(G/2j - FH 
F2 
ts 
r
"i t2s2 
2(xs-xs) 
bl t2s2 
^(Xg-Xg) , 
1 + 1 
nS nT 
+ (*oT " XT^ + ^S_aT"bTXoT^ 
Z(x^-x^)2 Z(xg-xg)2 
The two (l-a) per cent fiducial,limits are, therefore, 
XoS = XS + bs^aT+ bTXoT~YS^ ± ts 
Z(XS~Xg) 
t2s2 
Z(Xg-Xg) 2 
[bî - t2s2 1 1 + 1 + ^ xoT~XT^ + ^ S™aT™bTXoT^ 
Z(xs-xs) j nS nT 2(Xt-Xt)2i 
CM 
CO 
1 X
 C
O X 
(16) 
If g is defined as 
9 = WV(bg) t2s2 
bs 2^xs"xs^ 
then the expression for the limits "may be written as 
'oS 
+, 1 (aT+ B Y X ^ ^ - Y G )  ±  ^  bg(l-g) 1 + 1  
( 1-9) 
0 
bq bq 
o 
. 
ns nT 
+ ^ xoT~XT ^ + ^ s"aT™bTXoT^ 
2(Xt-Xt)2 _ Z(Xg-Xg) 
(17) 
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and if g is small then a shorter approximate expression for 
the limits may be obtained as 
XoS = XS + aT+bTXoT"yS ± 
n. 
+ 1 + 
T 
(xoT~xT) 
Z(xT-xT)' 
+ (ys"aT"bixoi) 
bs ^ xs~xs^ 
(18) 
In passing, it may be noted that the above formulas may 
be modified, as Finney (14, p. 472) shows for the standard 
parallel line assay, to include the quantal response (probit) 
case. The corresponding limits in this case are 
"oS XS + 1 
aT+bTXoT_yS ± t 
U-g) b 2 
bg(i-g) 1 + 1 
Znwx. Znwx 
T 
+ ^ xoT~XT^ 
T 
x x  
+ (ys"aT~bTxoT^ 
bs I-
where w is the probit weighting coefficient (14, p. 448) and 
Z is the weighted sums of squares. Mean values are also 
weighted and, in this case, 
9 = 
bl !xx 
where t is a normal deviate (1.96 for 95 per cent limits). 
c. Numerical example The following example is based 
on a quantitative response assay reported by Ing et_ al. (20) , 
in which one hundred mice were exposed at each of three doses 
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for two preparations. The standard preparation was atropine 
sulphate and the test preparation was designated as PJ_Q- The 
response y (pupil size) was measured in divisions (7.7 divi­
sions = 1 mm.). Doses z were measured in micrograms and the 
dose metameter x was x = log^z, giving xg = 1, 2, 3 and 
Xy — 1 5 2 J 3 . 
The original response data were not published in the 
paper and for the purposes of illustration here, the follow­
ing modifications were made. 
1. Approximate means of the observed responses at 
each dose were obtained from a graph. 
2 2. An estimate of cr was calculated from data given 
for a smaller, similar assay of atropine sulphate, 
where homoscedasticity was assumed (also assumed 
that cr2 = cr2 = cr2) . 
The following response means were obtained 
YS yT 
1 4.64 1 7.77 
2 9.11 2 10.80 
3 13.84 3 13.66. 
9 2 
The estimate of cr was calculated to be s = 60.27, which 
would have been based on 294 degrees of freedom in the orig­
inal analysis. 
The following quantities were computed to estimate the 
linear regressions for the two preparations separately. 
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= - .003  = 4 .853  
bg = 4.600 by = 2.945 
Yg =  9 .197  y  =  10 .743  
3 3 
Z (xT-xT)2 = Z (xc-xT)2 = 200, 
1 1 1 1 b 1 
where ng = nj ~ 300. 
Since s2 = s2 = s2 = s2 = 60.27 = .3013 = (.549)2 
S  T  2 ( x - ï ) 2  2 0 0  
it can be seen that bg and b are significantly different from 
zero and from each other. The estimates required in expression 
(13) are then 
C = aT " aS = 4.854  + .003  = 1.056 
b S  4 - 6  
D  =  =  2 . 9 4 5  =  0 . 6 4 0  
b S  4 ' 6  
Therefore, the estimated relationship between equally effective 
log doses of the two preparations is 
x =  1 .056  +  ( .640)xy .  (19)  
Transformation of this result into the original dose units 
yields 
z s  =  2 1 - 0 5 6 z . 6 4 0  =  2 . 0 7 9  z . 6 4 0 _  
The log dose (xQg) of atropine sulphate equivalent (in 
its ability to produce the response under consideration) to 
an arbitrary dose of preparation Pj_q^xoT^ ' may be estimated 
from Equation (19). If, for example, x _ =1.5, then 
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x 
oS = 1.056 + ( .640(1.5)  = 1.056 + .96 = 2.016 
and the corresponding dose is 
zQg = = 4.04 micrograms. 
In order to obtain 95 per cent fiducial limits, the 
following value was calculated: 
g = t2s2 = (4)(60.27) = .057.  
b2Z(Xg-Xg)2  (4.6)2(200) 
Use of Equation (16) yields the following limits for x 
oS 
xqS = 2 + .33810 ± 15.52 W(19.955)(.006667 + 0.25) 
19.955 19.955V 200 
+ .0054 
200 
= 2.0169 ± .3092 
= 1.71,  2.33 
Since g was found to be fairly small, the use of the simpler, 
more approximate limit formula (18) may be considered. In 
this case the calculated limits are 
x _ = 2 + .0735 ±15.52 .007917 + .0054 
4.6 V 4.6 4232 
= 2.016 + .300 
= 1.72,  2.32 ,  
and by comparison with the limits from the exact formula (16), 
it appears that limits found by the simpler approximate 
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formula are satisfactory in this case. 
d. Preliminary design considerations Finney 
(14, p. 175) has given a list of requirements of a good paral-
el line assay design with the aim of reducing the distance 
between the fiducial limits. It is accordingly of interest 
here to list corresponding desiderata in the general non-
parallel line situation. Consideration of Equation (17) 
shows that, in general, i v would be desirable to choose a 
design such that 
_ r\ _ ry 
1 .  Z( X y  -  x _ )  and Z(xg - x^) are both large 
2. (_1_ + _1_) is small 
nS nT 
3. st is small 
These requirements are the same as in the usual case discussed 
in detail by Finney, with the exception that bg (instead of a 
pooled b) appears in the denominator of C. 
It can also be seen from (17) that it is desirable that 
I a- + b_x _ - vJ and Ix - - xT| be small. The choice of 
T T OT • B1 1 oi 1 
doses may, therefore, also be influenced by the particular 
values of x _ which are of most interest to the experimenter. 
Design considerations in situations where the condition of 
similarity is not assumed constitute an area where further 
research could be done. Specific design requirements will 
vary with many factors including purpose of the assay and the 
particular field of application. 
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2. Other models 
Situations may arise in the analysis of bioassays where 
a linear model appears to be adequate for only one of the 
preparations, in which case the employment of a quadratic 
model for the other preparation may be a useful alternative. 
Two cases (a) and (b) below, may be distinguished according 
to whether the linear model is applicable to the standard 
preparation or to the test preparation. 
2 
a .  F g ( X g )  =  a g  +  p g X g ,  F y ( X y )  =  a T  +  P y X y  +  Y J x J  
Let Y = ag + pgxg, as in section. 1. Suppose that a quadratic 
model is appropriate for the log dose-response curve for T, 
o 
that is Y = + Py%y + YyXy , where the error assumptions 
are as before. In this case it can be seen that 
The above expression may be used to estimate the x _ equivalent 
to a specified xQy, where the usual regression estimators, 
as, bg, a-p, by, Cy, are substituted for ag, pg, ay, Py, yT. 
Fiducial limits for xQg may be obtained in a manner 
similar to that previously described. The expression for the 
limits in this case is 
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x_r. = xc + bS^aT+bTX0T+cTX0T~yS^ - + oS ts 
bs -
t2s2 
Zlxg-Xg) . 
t2s2 
Z(xg-xg) 
bt t2s2 
Z(xg-xg)2 
[V] + ^S"aT"bTXoT"CTXoT^ , 
Z(xg-xg)2 
where V = _1_ [Var(ag) + Var(a^) + x2yVar(bp) + x^Var(c^) 
s2 
+ 2xoTCov(aT,bT) + 2x2TCov(aT,cT) + 2x^Cov(b^,c^.)] T T • 'or 
2 2 
and s is the pooled estimate of a > as before. Estimates for 
the variances and covariances in V may be obtained from the 
two variance-covariance matrices used in estimating the 
regression parameters. 
b. Fg(xg) = as + jBgXg + Ysxs' = ax + Pjxy If 
2 
Y = ag + jBgXg + Ygxs anc* Yj = + p^x^, it can be seen that 
aS + ^ SX + YSXS aT + ^ TXT 
and 
-p q q - 4y g( Qg-Qj-p jX-j) (20) 
2r.< 
which is an expression of the relationship between equally 
effective log doses of S and T in terms of Xg. The above 
expression may be used to provide an estimate of the xQg 
equivalent to a specified x when, as before, the appro­
priate parameter estimates are substituted in (20). 
Fiducial limits for xQg are more difficult to compute, 
in this case, in that solving a quartic equation is involved. 
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As before, let a variable u be defined by 
u .= ag + bgXoS + CgXoS aT bTxoT-
This variable is normally distributed with an expected value 
of zero and variance 
V(u) = V(&g) + x^vfbg) """ *08^(^5) * 2%ogC:°v(ag,bg) 
+ 2x2gCov(ag,bg) + 2XggCov(bg,Cg) + V(a^) + x^v(b^) 
+ 2xoTCov(aT,bT) 
= a2 + %osV22g + *osV33g + 2*os/l2g 
+ 2xoS^13g + Zx^gVgg^ + 
2 2 2 if cfg = cTj = cr . The v's can be seen to be the usual elements 
of the inverse of the variance-covariance matrices used in 
determining the estimates of the parameters of the individual 
regression models. 
The values of xQg which correspond to the critical t 
values may be found in the same manner as before. Thus, 
(aS+bSXoS+CSXoS"aT"bTXoT^ 
s2(v11s+xOSV22s+xOSv33s+2xOSv12s+2xOSv13s+2xOSv23s+v11t 
where t is t^y^ with the degrees of freedom corresponding to 
o 
the degrees of freedom used in calculating s . Solving for 
Xgg in the above expression results in the following quartic 
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equation in x 
2b^CgX^p 22 S 
+ [2agbs - 2a^bg - 2bgb^.x^ 
23sbT*oT 
+ t2s2(vlls + V11T + 2x0Tv12t + xoTv22t)] 
0 
Methods for finding the roots of a quartic equation are 
available in most standard textbooks on the theory of equa­
tions. Adams (1) has designed a nomogram which may be of help 
in finding a quick approximate solution. Williams (33, p. 108-
has discussed the interpretation of possible solutions of a 
quartic equation which arose in a similar context, that of 
determining fiducial limits in an inverse estimation problem. 
If a quadratic model is employed for both preparations 
it is again necessary to solve a quartic equation to obtain 
the fiducial limits. Apart from the purely algebraic compu­
tations involved no differences in the general procedure arise 
in this case. 
It is interesting to note that Bliss (5), in 1957, sug­
gested the fitting of parallel quadratic functions, as an 
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alternative procedure to the parallel straight line model, 
when curvature is apparent which cannot satisfactorily be 
removed by a transformation. The decision as to whether a 
linear or quadratic model should be used in such an analysis 
is a special case of a problem in sequential model building, 
considered in a paper by Larson and Bancroft (22), in 1963, 
in which rules for making such a decision are examined in 
detail. 
Bliss (5) did not consider the possibility of violating 
the condition of monotonicity when a quadratic model is used. 
In such cases, if the model y = a + |3 x^ + yx^ ( i = 1, . . . , 
k) is fitted, then two linear restrictions which must be 
imposed on the parameters are 
P + ZyxjL > o 
P + 2yxk > o 
These restrictions insure that the first derivative is non-
negative and therefore that the function is non-decreasing 
between x^ and x^. The least squares fitting of polynomial 
function with linear constraints on the parameters is a 
problem in quadratic programming. Lewish (23) has considered 
this general problem in a study of linear estimation in convex 
parameter spaces. A numerical example of fitting a non-
decreasing quadratic function by least squares, based on 
theoretical developments given by Lewish, appears in Appendix B. 
This method is recommended for use whenever a quadratic model 
is employed to represent a response function in a bioassay. 
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V. SUMMARY 
The standard statistical methods for the analysis and 
interpretation of bioassays are based on a number of assump­
tions concerning the relevance of the mathematical model to 
the behavior of the experimental material. The usefulness of 
such methods depends upon the appropriateness of these assump­
tions in a particular bioassay. Situations arise, in bioas­
say studies, where some of the usual assumptions are not 
justified so that the standard statistical methods are 
inapplicable. This dissertation is concerned with the inves­
tigation of some of the basic assumptions used in bioassays, 
and the development of procedures applicable when they are 
not fulfilled. 
One basic assumption, which must be considered in the 
statistical analysis of all bioassays, is that the dose-
response function, F(z), is monotonie. Tests for monotonicity, 
where the parametric form of F(z) is not specified, are devel­
oped in Chapter II for both the quantal and quantitative 
response cases. 
Another assumption which is frequently made is that the 
response function is or can be made essentially linear, with 
respect to dose or log dose, by an appropriate transformation 
of the response variable. Standard tests of this assumption 
are available in the literature. When no exact parametric 
form, such as a linear model, for F(z) is assumed, an esti­
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mate of relative potency may still be made. This estimation 
problem is examined in Chapter III. 
For the relative potency of one preparation with respect 
to another to be a constant value, the condition of similarity 
must be valid. This condition requires that the test prepara­
tion must behave as though it were a dilution (or a concentra­
tion) of the standard preparation in an inert diluent. Tests 
for the hypothesis of similarity based on an assumed para­
metric form for F(z) are available for the usual models em­
ployed in bioassays. General methods for investigating 
similarity, without assuming an exact form for F(z), are given 
in Chapter II. 
Although all of the standard statistical procedures 
available for the analysis of bioassays are based on the 
assumption of similarity, many cases arise in practice in 
which this convenient assumption is violated. Examples of 
this situation in several bioassay studies have been cited. 
By the usual statistical procedures an assay is considered 
"invalid" if the hypothesis of similarity is rejected. Effi­
cient alternative procedures for analysis in such cases are 
not generally available. Methods for the analysis and presen­
tation of bioassay results when the assumption of similarity 
is not necessarily appropriate have been developed in Chapter IV. 
Depending upon the purpose of a particular assay, the 
"general" methods of analysis in Chapter IV may be of use 
even in cases where the hypothesis if similarity is not 
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rejected. At the expense of conciseness of presentation (a 
single value p), an estimate of the equivalent dose relation­
ship may provide a better representation of the true situa­
tion. The criteria for determining the optimum analysis and 
presentation of bioassay results, particularly with regard 
to the comparison of the standard and general methods of 
analysis, is an area which requires further investigation. 
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VIII. APPENDIX A 
In Chapter III a simple "average distance" estimator of 
log p (relative potency), in quantal response bioassays, was 
described for situations where the hypothesis of similarity 
is accepted and no parametric form for the cumulative log 
tolerance distribution, F(x), is specified. Information about 
the properties of this (or any other distribution-free esti­
mator) is difficult to obtain. Some preliminary considera­
tions of the variance and expectation of this estimator are 
presented in this appendix. 
A. Variance 
Suppose that the number of subjects exposed at each 
Xg^ (i = 1, 2, . . . , k) of the standard preparation is n^. 
Let the number of responses, y^, which occur at each independ­
ent Xg^, be binomially distributed with the true probability 
of a response equal to F ( xq.). Let, also, p„. = ^Si. Simi-
"Si 
larly define p_. = ^Tj for each x_. (j = 1, 2, . . ., k) of the 
nTj 
test preparation. The two response functions, Fg( Xg^ ) and 
Fj(xTj), are assumed to be of the same, but unknown, shape, 
and are horizontally separated by an unknown amount, M. 
An estimate, m, of the quantity, M, may be made at every 
x where p<^ is in the range of responses common to both 
preparations. For each such x_^, the corresponding m is 
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determined by the distance between x<^ and x^, where x_ is 
estimated by simple linear interpolation between the two 
Pyj's which bracket Let the two corresponding x^'s be 
designated as and xj(j+i)• An estimate of m may similarly 
be obtained for every p^ in the common response range. This 
procedure is described and illustrated in Chapter III. 
If h such estimates are obtained, the average distance 
estimator is 
h 
M = 1 ]>~ mr. 
^ r=l 
The variance of M is 
Var (M)= 1 [Z Var (m ) +22 Cov (m ,mç)], where 
h2 r r r/s r b 
a particular m^ may be written as 
"r = - xsi) • PS1 " PT3 ]• 
PT(j+l) " pTj 
The variance of involves the variances and covariance of 
the two terms within the brackets, and variance of (^ - x^^) 
depends upon the shape of F(x) in the range of experimentation, 
Therefore, the variance of an individual m , and hence the 
variance of M, cannot be determined without further informa­
tion about F(x). With further investigation, however, it may 
be possible to establish bounds for the variance of M by 
making certain assumptions about F(x) relative to the spacing 
of the x's. 
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B. Expectation 
Consider again, an individual estimate, 
"V = (*Tj - *Si) + 
'Si ~ PTj 
PT(j+l) ~ PTj 
The expectation of the above fraction obviously is between 0 
and 1. The expectation of (x^j - Xg^ ) is actually a condition­
al expectation, 
E[(Xij -
where A is the event that p^j < pg^ < Py(j+jj* 
It follows, therefore, that 
E[(xTj - xsi)jA] = 2[xTj - xsi] Pr[(xTj - xgi)|A], 
where the summation is taken over all possible values of 
(xTj - xgi) for which Pr[(x^j - xsi)[A]>0. 
The above probabilities depend upon the shape of F(x) in 
the area in which the Xg^'s and xjj's were chosen. As is the 
case with the variance, it would be impossible to establish 
bounds for the bias of M without making some assumptions about 
the shape of F(x) in this range. Although a number of such 
assumptions could be made, it appears difficult to define any 
one which would not be very nearly equivalent to the specifica­
tion of a parametric form for F(x). 
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IX. APPENDIX B 
2 If a quadratic function y = j3^ + p + P^xj_ (i = 1, 
. . .5 k) is used to represent the log dose-response relation­
ship in a bioassay, allowance must be made for the fact that 
such a response function must be monotonie; say non-decreasing, 
in the observed range (x-^ to x, ). In this appendix, a numeri­
cal example illustrating the fitting of a non-decreasing 
quadratic regression function by least squares is presented. 
Theoretical development of the general procedure for fitting 
non-decreasing polynomials was given by Lewish (23), in 1963. 
The problem in this case is to estimate the parameters of 
9 ~ 9 
y - ^ ^ t  ^2 X i  +  +  e i  '  e i  ~  N l  ( o ,  a  )  s u b j e c t  t o  t h e  
linear constraints 
§2 ^3xi — ® 
?2 + ^  3xk — ® 
where the x.'s are known. These constraints insure that the 
first derivative is non-negative (and therefore that the 
quadratic function is non-decreasing) between x^ and x,. 
Suppose the following hypothetical observations were made. 
= o y^ = 2 
x2 = l y2 = 7 
x3 = 
2 
• y3 = 9 
x4 = 3 y 4 =10 
The unconstrained least square estimates in this case are 
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p2 = 2.10, |3g - 5.60, jSg = -1.00. The second constraint is 
violated in this case since + 2^(3) = 5.60 - 6.00 = -0.4. 
If both constraints had been satisfied, of course the uncon­
strained solution would be equivalent to the constrained 
solution. 
The general method for determining the constrained solu­
tion, j3, is first to make an orthogonal transformation from 
the j3-space to y-space, as described by Lewish, and then make 
an orthogonal projection of y (unconstrained) to the parameter 
space, as defined by the linear constraints. Hartley (19) 
describes the construction of a triangular matrix A for making 
-1 
such a transformation, where y = A p. 
The matrix A in this example is 
A = 
1 -3 1 
2 2\/5 2 
0 _1 -3 
2 
0 0 1 
2 
The unconstrained y1 s may be found by the relationship T 
-1" f = A ^  
where 
-1 
2 
0 
0 
14.000 
5.814 
-2.000 
7 
n/5 15 
-/5 
0 2 
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The linear constraints in this case are 
^2 = &P3 > 0 « 
By the transformation Ay = j3 , these constraints in the y-space 
become 
.447 y2 " 1.500 y^ > 0 
.447 yg + 1.500 y% > 0 .  
The parameter space is, therefore, bounded by the lines 
y2 = 3.354 yg 
Y2 = -  3.354 y^ 
The point y^, y3 (5.814, - 2.000) lies outside the para­
meter space but close to the boundary line yg = -3.354 y^. The 
orthogonal projection from this point to the line will deter­
mine the constrained solution, y. It can be seen that 
^ y 2 - (3.354) (^ 
Ï3 
(3.354)2+1 
= -2.000 - (3.354)(5.814) 
12.249 
= -1.76, 
and yg = 5.90. 
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Thus 
Y 
14.00  
5 .90  
-1.76 
The transformation of y back into the (3-space by the trans­
formation = Ay yields 
2.16 
P =  5 .28  
-0 .88  
which is the least square solution under the constraints. It 
can be seen that both constraints on the (31 s are now satisfied, 
since ^  > 0 and ^  + 6j3g = 0. 
